A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses (TTIP-PRO)

University of Cincinnati

Status: Completed

Conditions: Opioid-Related Disorders; Drug Abuse; Substance Abuse; Drug Addiction; Drug Overdose

Treatments: Behavioral: Peer Intervention; Drug: naloxone nasal spray kit; Behavioral: Personally-tailored opioid overdose prevention education (information packet)

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT02922959

R34DA040862 (U.S. NIH Grant/Contract)

2016-6635

Details and patient eligibility

About

This project will further develop and test the Tailored Telephone Intervention delivered by Peers to Prevent Recurring Opioid Overdoses (TTIP-PRO), a promising, low-cost, intervention to facilitate entry into medication assisted treatment (MAT) for individuals experiencing a non-fatal opioid overdoses (OOD). A prior small-scale pilot/feasibility study of TTIP-PRO (NCT02282306) found that the participating patients and the Peer Interventionists were satisfied with their participation, the intervention was acceptable, and the system for generating patient-tailored intervention information performed well. The overall goal of the present study is to conduct a pilot randomized controlled trial of TTIP-PRO versus a control group. It is hypothesized that patients in the TTIP-PRO group will have more favorable drug-abuse-related outcomes than patients in the control group.

Full description

This pilot study is a randomized controlled intent-to-treat (ITT) clinical trial. Approximately eighty eligible participants will be randomized in a 1:1 ratio to the control condition (Information and NARCAN® (naloxone) Nasal Spray kit) or to the experimental condition (TTIP-PRO in addition to the elements provided in the control condition). All participants will complete a follow-up phone call approximately 3-weeks post-randomization, during which process measures will be completed, and in-person visits at approximately 3, 6-, and 12-months following enrollment.

This is a single site study; all data will be collected at the University of Cincinnati. Approximately 80 participants will be randomized into this pilot efficacy trial. The hypotheses to be tested include that participants assigned to the TTIP-PRO intervention will: have a higher rate of enrollment in MAT, have a lower rate of recurring opioid overdose, and have greater reduction in illicit opioid use.

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Report having been treated for an OOD within the past 6 months
• Age 18 years or older;
• Scores "high risk" for heroin and/or non-medical use of prescription opioids on the National Institute on Drug Abuse modified Alcohol, Smoking and Substance Involvement Screening Test (NIDA-modified ASSIST) (i.e., ≥ 27)
• Be able to understand the study, and having understood, provide written informed consent in English
• Access to a phone (for TTIP-PRO intervention and phone follow-up)
• Be willing to have their intervention audio recorded and rated if randomized to TTIP-PRO
• Have an opioid-positive baseline/screening urine drug screen.

Exclusion criteria

• In the judgment of the investigator, would not be expected to complete the study protocol (e.g., due to relocation from the clinic area, probable incarceration, etc.)
• Current engagement in addiction treatment
• Residence more than 40 miles from the location of follow-up visits
• Inability to provide sufficient contact information (must provide at least 2 reliable locators)
• Prior participation in the current study.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

80 participants in 2 patient groups

PTOEND

Active Comparator group

Description:

PTOEND: Personally-tailored opioid overdose prevention education and naloxone distribution. Participants in this arm will be given a NARCAN (naloxone) nasal spray kit and personally-tailored information packet about opioid overdose and treatment.

Treatment:

Drug: naloxone nasal spray kit

Behavioral: Personally-tailored opioid overdose prevention education (information packet)

PTOEND+PI

Experimental group

Description:

PTOEND+PI: Personally-tailored opioid overdose prevention education and naloxone distribution, plus Peer Intervention. In addition to a NARCAN (naloxone) nasal spray kit and personally-tailored information packet about opioid overdose and treatment, participants randomized to this arm will also receive the experimental Peer Intervention.

Treatment:

Drug: naloxone nasal spray kit

Behavioral: Peer Intervention

Behavioral: Personally-tailored opioid overdose prevention education (information packet)